EP0749319A4 - IMMORTALIZED CELLS AND USES THEREOF - Google Patents

IMMORTALIZED CELLS AND USES THEREOF

Info

Publication number: EP0749319A4
Authority: EP; European Patent Office
Prior art keywords: immortalized cells; immortalized; cells
Prior art date: 1992-09-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19930920511

Other languages

German (de)

French (fr)

Other versions

EP0749319A1 (en

Inventor

Timothy J Miller

Stephen K Wikel

Rangappa N Ramachandra

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Corp Belgium

Pfizer Corp SRL

Oklahoma State University

Original Assignee

Pfizer Corp Belgium

Pfizer Corp SRL

Oklahoma State University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-14

Filing date

1993-09-14

Publication date

1996-09-16

1993-09-14 Application filed by Pfizer Corp Belgium, Pfizer Corp SRL, Oklahoma State University filed Critical Pfizer Corp Belgium

1996-09-16 Publication of EP0749319A4 publication Critical patent/EP0749319A4/en

1996-12-27 Publication of EP0749319A1 publication Critical patent/EP0749319A1/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Mycology (AREA)
Physics & Mathematics (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Insects & Arthropods (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP93920511A 1992-09-14 1993-09-14 Immortalized cells and uses therefor Withdrawn EP0749319A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94487392A	1992-09-14	1992-09-14
US944873		1992-09-14
PCT/US1993/008606 WO1994006463A1 (en)	1992-09-14	1993-09-14	Immortalized cells and uses therefor

Publications (2)

Publication Number	Publication Date
EP0749319A4 true EP0749319A4 (en)	1996-09-16
EP0749319A1 EP0749319A1 (en)	1996-12-27

Family

ID=25482205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93920511A Withdrawn EP0749319A1 (en)	1992-09-14	1993-09-14	Immortalized cells and uses therefor

Country Status (5)

Country	Link
EP (1)	EP0749319A1 (en)
JP (1)	JPH08502646A (en)
AU (2)	AU5103293A (en)
CA (1)	CA2144651A1 (en)
WO (1)	WO1994006463A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2357215T3 (en)	1996-10-16	2011-04-20	Zymogenetics, Inc.	HOMOLOGISTS OF THE FIBROBLAST GROWTH FACTOR.
US6017757A (en) *	1997-02-20	2000-01-25	Mississippi State University	Isolated viable nematode intestinal cells
KR20010085838A (en)	1998-09-23	2001-09-07	리스 데브라 케이.	Cytokine receptor zalpha11
ATE404668T1 (en)	1998-12-07	2008-08-15	Zymogenetics Inc	GROWTH FACTOR HOMOLOGUE ZVEGF-3
ES2338661T3 (en)	1999-01-07	2010-05-11	Zymogenetics, Inc.	THERAPEUTIC USES OF BR43X2 SOLUBLE RECEIVERS.
US7833529B1 (en)	1999-01-07	2010-11-16	Zymogenetics, Inc.	Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
PL207350B1 (en)	1999-03-09	2010-12-31	Zymogenetics Inc	Novel cytokine zalpha11 ligand
CA2395369C (en)	1999-12-23	2014-07-08	Zymogenetics, Inc.	Cytokine zcyto18
PT1325115T (en)	2000-06-26	2016-09-28	Zymogenetics Inc	Cytokine receptor zcytor17
EP1451322B1 (en)	2001-11-05	2009-09-30	ZymoGenetics, Inc.	Il-21 antagonists
AU2003280410B8 (en)	2002-01-18	2009-04-23	Zymogenetics, Inc.	Cytokine receptor zcytor17 multimers
CN100575482C (en)	2002-01-18	2009-12-30	津莫吉尼蒂克斯公司	New cytokine ZCYTOR 17 ligand
CN1659274A (en)	2002-04-19	2005-08-24	津莫吉尼蒂克斯公司	Cytokine receptor
PT2251353E (en)	2003-08-07	2013-05-07	Zymogenetics Inc	Homogeneous preparations of il-29
EP1732946B1 (en)	2004-03-08	2011-07-27	ZymoGenetics, Inc.	Dimeric fusion proteins and materials and methods for producing them
CN101829318B (en)	2004-07-29	2012-07-04	津莫吉尼蒂克斯有限责任公司	Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
EA016083B1 (en)	2005-08-09	2012-02-28	Займоджинетикс, Инк.	Methods for treating b-non-hodgkin's lymphoma using taci-ig fusion molecule
AR059025A1 (en)	2005-08-09	2008-03-12	Zymogenetics Inc	METHODS FOR THE TREATMENT AND PREVENTION OF PROLIFERATION OF ABNORMAL CELLS USING TACI FUSION MOLECULES
EA015342B1 (en)	2006-05-15	2011-06-30	Арес Трейдинг С.А.	Methods for treating autoimmune diseases using a taci-ig fusion molecule
US7754689B2 (en)	2006-06-02	2010-07-13	Wyeth Llc	Finger-1 peptide analogs of the TGF-β superfamily
JP2009539767A (en)	2006-06-02	2009-11-19	ワイス	Use of TGF-β superfamily proteins and peptides for purification and therapeutic methods
CA2668405C (en) *	2006-11-03	2015-05-05	Schering-Plough Ltd.	Canine lyme disease vaccine
EP2164863A4 (en)	2007-06-15	2010-07-28	Univ Arkansas	METHODS OF DISPENSING MOLECULE TO CELLS USING RICIN SUBUNIT AND ASSOCIATED COMPOSITIONS
EP2604279A1 (en)	2008-03-27	2013-06-19	ZymoGenetics, Inc.	Compositions and methods for inhibiting PDGFRBETA and VEGF-A
EP2313105B1 (en)	2008-06-27	2013-07-24	ZymoGenetics, Inc.	SOLUBLE HYBRID Fc gamma RECEPTORS AND RELATED METHODS
MX2012013899A (en)	2010-06-09	2013-03-20	Zymogenetics Inc	Dimeric vstm3 fusion proteins and related compositions and methods.
CN104220602B (en)	2012-02-01	2018-10-30	合成基因组股份有限公司	The material and method of nucleic acid molecules are minimized for resultant fault
AU2016321146C1 (en)	2015-09-08	2021-10-28	Theripion, Inc.	ApoA-1 fusion polypeptides and related compositions and methods
WO2018136163A2 (en)	2016-12-09	2018-07-26	Theripion, Inc.	Tandem apoa-1 fusion polypeptides
IL272103B2 (en)	2017-07-20	2024-10-01	Aptevo Res & Development Llc	Antigen-binding proteins that bind to 5T4 and 4-1BB, as well as compositions and methods for treating cancer related to them
US11098122B2 (en)	2017-12-20	2021-08-24	Harbour Biomed (Shanghai) Co., Ltd.	Antibodies binding CTLA-4 and uses thereof
US10150801B1 (en)	2017-12-27	2018-12-11	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
CN111801346B (en)	2017-12-27	2024-08-09	免疫实验室私人有限公司	Recombinant polypeptides and methods of use thereof
US10675332B1 (en)	2019-08-26	2020-06-09	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
EP4021512A1 (en)	2019-08-26	2022-07-06	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
EP4168034A1 (en)	2020-06-22	2023-04-26	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and combinations for use in the treatment of cancer
JP2024507220A (en)	2021-02-19	2024-02-16	セリピオン，インコーポレイテッド	Paraoxonase fusion polypeptides and related compositions and methods
WO2024148328A2 (en)	2023-01-06	2024-07-11	Aptevo Research And Development Llc	Bispecific pd-l1 and cd40 binding molecules and uses thereof
WO2024259220A1 (en)	2023-06-15	2024-12-19	Theripion, Inc.	Pon3 and evolved pon1 fusion polypeptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988003929A1 (en) *	1986-11-27	1988-06-02	Biotechnology Australia Pty. Ltd.	Vaccine containing tick antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4447537A (en) *	1981-01-22	1984-05-08	The United States Of Americas As Represented By The Department Of Health And Human Services	Tick cell lines
US5186933A (en) *	1986-12-30	1993-02-16	Baylor College Of Medicine	Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

1993
- 1993-09-14 EP EP93920511A patent/EP0749319A1/en not_active Withdrawn
- 1993-09-14 WO PCT/US1993/008606 patent/WO1994006463A1/en not_active Application Discontinuation
- 1993-09-14 JP JP6508223A patent/JPH08502646A/en active Pending
- 1993-09-14 AU AU51032/93A patent/AU5103293A/en not_active Abandoned
- 1993-09-14 CA CA002144651A patent/CA2144651A1/en not_active Abandoned
1997
- 1997-12-11 AU AU48314/97A patent/AU4831497A/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988003929A1 (en) *	1986-11-27	1988-06-02	Biotechnology Australia Pty. Ltd.	Vaccine containing tick antigens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9406463A1 *

Also Published As

Publication number	Publication date
JPH08502646A (en)	1996-03-26
EP0749319A1 (en)	1996-12-27
AU4831497A (en)	1998-03-26
CA2144651A1 (en)	1994-03-31
WO1994006463A1 (en)	1994-03-31
AU5103293A (en)	1994-04-12

Publication	Publication Date	Title
EP0749319A4 (en)	1996-09-16	IMMORTALIZED CELLS AND USES THEREOF
EP0841950A4 (en)	2000-01-19	NEURONAL STEM CELLS AND USES THEREOF
NO931864D0 (en)	1993-05-21	CELL INHIBITION - ADHESION PROTEIN - CARBOHYDRATE - REACTIONS
KR950701068A (en)	1995-02-20	Load cell
EP1009415A4 (en)	2000-10-25	INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES
NO981988D0 (en)	1998-04-30	Cell Confinement Structure
DE69316628D1 (en)	1998-02-26	Volatile memory cell
DE69434300D1 (en)	2005-04-21	SOLAR CELL
FR2543743B1 (en)	1987-04-24	ELECTROCHEMICAL CELLS AND THEIR CATHODES
DE59010020D1 (en)	1996-02-15	Static memory cell
DK162790D0 (en)	1990-07-06	PLANT CELL
BR8901337A (en)	1989-11-07	CAGE AND ROLLER SET
DE69302341D1 (en)	1996-05-30	Lithium cell
FI961072A0 (en)	1996-03-07	Solid state electrochemical cell
ITMI931118A0 (en)	1993-05-31	IMMORTALIZED DENDRITIC CELLS
FR2635329B1 (en)	1993-12-03	AMORPHOUS COPOLYAMIDES AND USES THEREOF
MX165000B (en)	1992-10-13	IMPROVED LAMINAR SEPARATOR AND ACCUMULATOR
FR2670215B1 (en)	2000-10-13	LINES OF IMMORTALIZED CELLS AND THEIR APPLICATIONS, IN PARTICULAR FOR THE PRODUCTION OF DIFFERENTIATED CELLS.
FR2740680B1 (en)	1997-12-12	SOLID COSMETIC COMPOSITION AND USES
NO955036L (en)	1995-12-12	Building modules and constructions formed by such modules
DE69229717D1 (en)	1999-09-09	Trench DRAM cell matrix
DK0462790T3 (en)	1997-06-16	Building and construction method
DE69120367D1 (en)	1996-07-25	Charge transfer and / or amplification arrangement
FI961848A0 (en)	1996-04-30	Improved cell culture method and agents
FR2576020B1 (en)	1989-12-08	5-HALOPYRIDINE-3-CARBOXAMIDES AND THEIR APPLICATIONS

Legal Events

Date	Code	Title	Description
1996-09-16	A4	Supplementary search report drawn up and despatched
1996-09-16	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1996-11-08	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1996-12-27	17P	Request for examination filed	Effective date: 19950711
1996-12-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1998-11-18	17Q	First examination report despatched	Effective date: 19981002
1999-06-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1999-08-11	18D	Application deemed to be withdrawn	Effective date: 19990213